These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37066059)

  • 1. Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011-2020).
    Orru' S; Oberle D; Heiden M; Müller S; Krut O; Funk MB
    Transfus Med Hemother; 2023 Apr; 50(2):144-153. PubMed ID: 37066059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010).
    Funk MB; Lohmann A; Guenay S; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
    Transfus Med Hemother; 2011; 38(4):266-271. PubMed ID: 22016698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008.
    Lafeuillade B; Eb F; Ounnoughene N; Petermann R; Daurat G; Huyghe G; Vo Mai MP; Caldani C; Rebibo D; Weinbreck P
    Transfusion; 2015 Mar; 55(3):636-46. PubMed ID: 25257344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections.
    Richard P; Pouchol E; Sandid I; Aoustin L; Lefort C; Chartois AG; Baima A; Malard L; Bacquet C; Ferrera-Tourenc V; Gallian P; Laperche S; Bliem C; Morel P; Tiberghien P
    Vox Sang; 2024 Mar; 119(3):212-218. PubMed ID: 38152857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013).
    Funk MB; Heiden M; Volkers P; Lohmann A; Keller-Stanislawski B
    Transfus Med Hemother; 2015 Jul; 42(4):240-6. PubMed ID: 26557816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet safety strategies in Japan: impact of short shelf life on the incidence of septic reactions.
    Satake M; Kozakai M; Matsumoto M; Matsubayashi K; Taira R; Goto N
    Transfusion; 2020 Apr; 60(4):731-738. PubMed ID: 32119134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of measures aimed to reduce serious adverse transfusion reactions (hemovigilance data from 1997 to 2008)].
    Funk MB; Günay S; Lohmann A; Henseler O; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Apr; 53(4):347-56. PubMed ID: 20213431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German Haemovigilance System--reports of serious adverse transfusion reactions between 1997 and 2007.
    Keller-Stanislawski B; Lohmann A; Günay S; Heiden M; Funk MB
    Transfus Med; 2009 Dec; 19(6):340-9. PubMed ID: 19725904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.
    Pitman JP; Payrat JM; Park MS; Liu K; Corash L; Benjamin RJ
    Transfusion; 2023 Apr; 63(4):711-723. PubMed ID: 36802055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.
    Jutzi M; Mansouri Taleghani B; Rueesch M; Amsler L; Buser A
    Transfus Med Hemother; 2018 May; 45(3):151-156. PubMed ID: 29928168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Report on notifications pursuant to Section 21 German Transfusion Act for 2007].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):715-31. PubMed ID: 19572110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007. Groupe de travail–validation des IBTT (Working group for validation of transfusion-transmitted bacterial infections)].
    Delbosc A; Lafeuillade B; Petermann R; Eb F; Ounnoughene N
    Transfus Clin Biol; 2011 Feb; 18(1):26-35. PubMed ID: 21310643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
    Huber J; Stanworth SJ; Doree C; Fortin PM; Trivella M; Brunskill SJ; Hopewell S; Wilkinson KL; Estcourt LJ
    Cochrane Database Syst Rev; 2019 Nov; 11(11):CD012745. PubMed ID: 31778223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data.
    Berg P; Heiden M; Müller S; Meyer B; Witzenhausen C; Ruppert-Seipp G; Kehr S; Funk MB
    Vox Sang; 2024 Sep; 119(9):953-962. PubMed ID: 38889998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive Blood Transfusion in Patients with Ruptured Abdominal Aortic Aneurysm.
    Montan C; Hammar U; Wikman A; Berlin E; Malmstedt J; Holst J; Wahlgren CM
    Eur J Vasc Endovasc Surg; 2016 Nov; 52(5):597-603. PubMed ID: 27605360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.